Published in BMB Rep on October 01, 2014
The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer (2002) 28.11
Untangling the ErbB signalling network. Nat Rev Mol Cell Biol (2001) 28.05
ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer (2005) 16.73
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell (2002) 5.64
Transdermal drug delivery. Nat Biotechnol (2008) 5.11
Signaling networks assembled by oncogenic EGFR and c-Met. Proc Natl Acad Sci U S A (2008) 5.08
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell (2005) 3.67
A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling. Mol Cell Biol (2000) 3.04
The "Gab" in signal transduction. Trends Cell Biol (2003) 2.52
The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol (2007) 2.17
Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer (2002) 2.16
EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat (2006) 1.92
Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res (2004) 1.71
A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor. J Biol Chem (2000) 1.56
Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell Signal (2001) 1.48
A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J Biol Chem (2005) 1.47
Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. EMBO J (2002) 1.43
The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. Atherosclerosis (2005) 1.39
Biologically active synthetic fragments of epidermal growth factor: localization of a major receptor-binding region. Proc Natl Acad Sci U S A (1984) 1.31
Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways. Int J Biochem Cell Biol (2007) 1.05
EGFR-ras-raf signaling in epidermal stem cells: roles in hair follicle development, regeneration, tissue remodeling and epidermal cancers. Int J Mol Sci (2013) 1.02
Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation. J Dermatol Sci (2013) 0.88
Peptide mimics of epidermal growth factor (EGF) with antagonistic activity. J Biotechnol (2005) 0.86
The use of growth factors and other humoral agents to accelerate and enhance burn wound healing. Eplasty (2011) 0.85
Recent advances in functional region prediction by using structural and evolutionary information - Remaining problems and future extensions. Comput Struct Biotechnol J (2013) 0.80
A specific binding site for a fragment of the B-loop of epidermal growth factor and related peptides. Peptides (2002) 0.78